NSAID Use Associated With Shorter PFS, OS in Metastatic RCC

A pooled retrospective analysis of nearly 5,000 mRCC patients in phase II and III trials showed PFS among NSAIDs users was half that of NSAIDs nonusers.

Source: CancerNetwork - May 7, 2018 Category: Cancer & Oncology Authors: John Schieszer Tags: News Renal Cell Carcinoma Source Type: news